PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-12.95%
Negative net income growth while AVGO stands at 12.35%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
6.84%
Some D&A expansion while AVGO is negative at -15.13%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
95.38%
Some yoy growth while AVGO is negative at -543.82%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
67.74%
SBC growth well above AVGO's 1.03%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-9488.89%
Both reduce yoy usage, with AVGO at -64.59%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-87.59%
Both yoy AR lines negative, with AVGO at -14.52%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-50.42%
Negative yoy inventory while AVGO is 129.89%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-464.71%
Both negative yoy AP, with AVGO at -126.32%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-236.97%
Negative yoy usage while AVGO is 23.71%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
1.59%
Some yoy increase while AVGO is negative at -111.11%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-43.19%
Both yoy CFO lines are negative, with AVGO at -11.94%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-1.55%
Negative yoy CapEx while AVGO is 15.57%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
18.30%
Purchases growth of 18.30% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
10.30%
Liquidation growth of 10.30% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
81.82%
We have some outflow growth while AVGO is negative at -100.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
102.73%
Investing outflow well above AVGO's 19.53%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-274.84%
Both yoy lines negative, with AVGO at -2788.89%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
70.00%
We slightly raise equity while AVGO is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
87.85%
We have some buyback growth while AVGO is negative at -455.11%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.